Invitris developed PhactoryTM, a cell-free expression platform, to create novel protein structures from scratch. Invitris partners PhactoryTM with other life science companies to rapidly develop & scale GMP manufacturing of antibodies, bispecific antibodies, nanobodies, membrane proteins, bacteriophages, endolysins, and OMVs - completely in vitro.